Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00966823 · ClinicalTrials.gov registry record · Phase 2
Fetal Tracheal Balloon Study in Diaphragmatic Hernia
A Phase 2 study, sponsored by Rhode Island Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00966823 is a Phase 2 study that was terminated before completion, run by Rhode Island Hospital. The registered enrollment target is 3 participants.
The verdict
NCT00966823, a Phase 2 study, was terminated before completion, sponsored by Rhode Island Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this phase 2 limited study is to examine whether prenatal intervention correct the lung underdevelopment associated with severe diaphragmatic hernia.
Interventions
- DEVICE Fetal tracheal obstruction with detachable balloon (device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00966823
The ClinicalTrials.gov registry entry for NCT00966823 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fetal tracheal obstruction with detachable balloon (device) is the first listed.
NCT00966823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00966823 about?
NCT00966823 is a clinical study titled "Fetal Tracheal Balloon Study in Diaphragmatic Hernia". The purpose of this phase 2 limited study is to examine whether prenatal intervention correct the lung underdevelopment associated with severe diaphragmatic hernia.
What is the current status of trial NCT00966823?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2008-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00966823?
The interventions under investigation include: Fetal tracheal obstruction with detachable balloon (device) (DEVICE).
Who is sponsoring clinical trial NCT00966823?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.